Press Releases

WCG CenterWatch Celebrates Excellence in Clinical Trial Collaborations with Inaugural Pinnacle Award for Site Relationships

WCG proudly announces the winners of the first-ever prestigious WCG Pinnacle Award, Site Relationships. Award winners were chosen based on the results of WCG’s 2025 CenterWatch Global Site Relationship Survey that captured insights from more than 12,000 respondents.

MIB Agents' Community of Families Has Awarded $2.5M in Grants to Research Pediatric Bone Cancer

MIB Agents, a leading pediatric osteosarcoma nonprofit, announced it has awarded $2.5 million in research grants through its OutSmarting Osteosarcoma program, which is powered by families honoring children affected by the disease. At its upcoming FACTOR Conference (June 26–28) in Salt Lake City, the organization will award $700,000 in grants to 10 scientists advancing less toxic, more effective treatments. The grants, which include four $100,000 Hero Grants and six $50,000 Hope Young Investigator Grants, reflect a unique collaboration between researchers and the osteosarcoma community, with families actively funding and participating in the review of scientific proposals.

Ceryx Medical Secures $15 Million to Advance Groundbreaking Heart Failure Technology

Ceryx Medical today announced the successful close of a new funding round, bringing the company’s total raised to $15 million.

Phenomix and Mayo Clinic Publish Research Demonstrating Utility of MyPhenome Test for Personalized GLP-1 and Phen-Top Treatment

Published in Cell Metabolism, the Phenomix and Mayo Clinic research shows the MyPhenomeTM test can help providers guide obesity treatment by matching patients to GLP-1s or phentermine/topiramate based on their unique biology.

Veloxity Labs Announces NIL Partnership with Bradley University Track Star Carolina Martinez

Veloxity Labs has announced a new NIL (Name, Image and Likeness) partnership with Carolina Martinez, a standout sprinter at Bradley University and childhood cancer survivor. The collaboration reflects a shared commitment to science, community and purpose. Diagnosed with leukemia at age five, Carolina beat the odds—and now competes at the highest collegiate level, recently breaking a 41-year-old school record in the 300-meter dash. Her story of resilience and recovery deeply aligns with Veloxity’s mission: to accelerate therapeutic development and improve lives through high-quality, fast-turnaround bioanalytical testing. The partnership marks Veloxity’s first NIL collaboration and centers on the power of people-first science. Together, Veloxity and Carolina are sharing a message of hope and determination—most recently through a new commercial campaign filmed in Peoria.

Tjoapack continues to expand its global infrastructure with strategic investments in injectable packaging and cold chain capabilities

Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials

Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery.

Inizio Evoke Announces Medical Leadership Evolution: Matthew Hoelzle Named Chief Medical Officer

Industry Leading RBQM Event Returns for 2025

CluePoints, the premier sponsor of RBQMLive and provider of leading statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual, award-winning event, RBQMLive.

Image Analysis Group (IAG) and Picture Health Announce Strategic Partnership to Advance AI-Driven Imaging Endpoints in Oncology Clinical Trials

IAG (imaging CRO) and Picture Health (AI biomarker platform) just announced a partnership to advance the use of AI-driven imaging biomarkers in oncology trials. This partnership brings together IAG’s expertise and its DYNAMIKA™ AI platform with Picture Health’s Px™ platform and multimodal AI biomarkers. Together, they aim to deliver: Faster insights Smarter patient stratification Earlier, more in-depth reads into oncology treatment outcomes Both companies are women-led, AI-driven, and deeply committed to reshaping clinical research through advanced imaging analytics.

New Mayo Clinic Studies Find MyPhenome Test Predicts Recurrent Weight Regain After Bariatric Surgery

Research presented at Digestive Disease Week 2025 is the first to show that the MyPhenome test can identify patients at risk for weight regain and those most likely to benefit from bariatric procedures.

Enhancing Clinical Trials for Faster, More Predictable Outcomes with WCG Study Accelerator

WCG Clinical has announced the launch of WCG Study Accelerator, an innovative solution built to streamline clinical trial processes and improve outcomes for sponsors and institutions worldwide.

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

This partnership will launch three new START research sites to bring early phase trials closer to patients in major U.S. communities.

Verista Highlights LABELQ Print and Inspection Verification System

Verista, a leading provider of automation, compliance, and quality solutions for the pharmaceutical industry, highlights the LABELQ Label & Print Reconciliation System, a groundbreaking platform engineered to transform label management for medical device, pharmaceutical, and contract manufacturers. LABELQ streamlines operations by integrating print, inspection, and accountability into a single, unified platform, significantly increasing efficiency and reducing operational complexity for small and medium batch production environments.

Astoriom Expands Global Footprint for Sample Stability Storage Services

Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions

eClinical Solutions Welcomes Sean Lannan as Chief

Lannan and new Board of Directors member Jason Blessing will help propel the company’s next phase of growth

Abzena Announces Establishment of Scientific Advisory Board to Support Innovation Strategy

CapeStart Helps Life Science Teams Scale Faster, Boost Productivity with New Release of MadeAi™, Award-Winning GenAI Platform

CapeStart announced a major new release of MadeAi™, its GenAI-based platform that expedites the synthesis of content and data for the life sciences. The platform and the MadeAi-LR solution for systematic literature review (SLR) help time-strapped teams to advance the pace of scientific research.

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

This major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials.

Inizio Evoke Supercharges Creative Leadership with Dual ECD Appointments